Literature DB >> 16847342

Understanding the molecular basis of the interaction between NDPK-A and AMPK alpha 1.

Russell M Crawford1, Kate J Treharne, Sandrine Arnaud-Dabernat, Jean-Yves Daniel, Marc Foretz, Benoit Viollet, Anil Mehta.   

Abstract

Nucleoside diphosphate kinase (NDPK) (nm23/awd) belongs to a multifunctional family of highly conserved proteins (approximately 16 to 20 kDa) including two well-characterized isoforms (NDPK-A and -B). NDPK catalyzes the conversion of nucleoside diphosphates to nucleoside triphosphates, regulates a diverse array of cellular events, and can act as a protein histidine kinase. AMP-activated protein kinase (AMPK) is a heterotrimeric protein complex that responds to the cellular energy status by switching off ATP-consuming pathways and switching on ATP-generating pathways when ATP is limiting. AMPK was first discovered as an activity that inhibited preparations of acetyl coenzyme A carboxylase 1 (ACC1), a regulator of cellular fatty acid synthesis. We recently reported that NDPK-A (but not NDPK-B) selectively regulates the alpha1 isoform of AMPK independently of the AMP concentration such that the manipulation of NDPK-A nucleotide trans-phosphorylation activity to generate ATP enhanced the activity of AMPK. This regulation occurred irrespective of the surrounding ATP concentration, suggesting that "substrate channeling" was occurring with the shielding of NDPK-generated ATP from the surrounding medium. We speculated that AMPK alpha1 phosphorylated NDPK-A during their interaction, and here, we identify two residues on NDPK-A targeted by AMPK alpha1 in vivo. We find that NDPK-A S122 and S144 are phosphorylated by AMPK alpha1 and that the phosphorylation status of S122, but not S144, determines whether substrate channeling can occur. We report the cellular effects of the S122 mutation on ACC1 phosphorylation and demonstrate that the presence of E124 (absent in NDPK-B) is necessary and sufficient to permit both AMPK alpha1 binding and substrate channeling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847342      PMCID: PMC1592779          DOI: 10.1128/MCB.00315-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

Review 1.  AMP-activated protein kinase: the energy charge hypothesis revisited.

Authors:  D G Hardie; S A Hawley
Journal:  Bioessays       Date:  2001-12       Impact factor: 4.345

Review 2.  Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with multiple partners: possible consequences in tumor metastasis.

Authors:  D Roymans; R Willems; D R Van Blockstaele; H Slegers
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

3.  Histidine phosphorylation of annexin I in airway epithelia.

Authors:  R Muimo; Z Hornickova; C E Riemen; V Gerke; H Matthews; A Mehta
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 4.  Knockout mice as model systems for studying nm23/NDP kinase gene functions. Application to the nm23-M1 gene.

Authors:  S Arnaud-Dabernat; P M Bourbon; A Dierich; M Le Meur; J Y Daniel
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

5.  No evidence for inhibition of ENaC through CFTR-mediated release of ATP.

Authors:  Jens König; R Schreiber; M Mall; K Kunzelmann
Journal:  Biochim Biophys Acta       Date:  2002-09-20

Review 6.  Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models.

Authors:  B Viollet; F Andreelli; S B Jørgensen; C Perrin; D Flamez; J Mu; J F P Wojtaszewski; F C Schuit; M Birnbaum; E Richter; R Burcelin; S Vaulont
Journal:  Biochem Soc Trans       Date:  2003-02       Impact factor: 5.407

7.  The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

Authors:  Benoit Viollet; Fabrizio Andreelli; Sebastian B Jørgensen; Christophe Perrin; Alain Geloen; Daisy Flamez; James Mu; Claudia Lenzner; Olivier Baud; Myriam Bennoun; Emmanuel Gomas; Gaël Nicolas; Jørgen F P Wojtaszewski; Axel Kahn; David Carling; Frans C Schuit; Morris J Birnbaum; Erik A Richter; Rémy Burcelin; Sophie Vaulont
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle.

Authors:  Jakob N Nielsen; Kirsty J W Mustard; Drew A Graham; Haiyan Yu; Christopher S MacDonald; Henriette Pilegaard; Laurie J Goodyear; D Grahame Hardie; Erik A Richter; Jørgen F P Wojtaszewski
Journal:  J Appl Physiol (1985)       Date:  2002-10-11

9.  Creatine kinase is physically associated with the cardiac ATP-sensitive K+ channel in vivo.

Authors:  Russell M Crawford; Harri J Ranki; Catherine H Botting; Grant R Budas; Aleksandar Jovanovic
Journal:  FASEB J       Date:  2001-11-29       Impact factor: 5.191

10.  Ageing is associated with a decrease in the number of sarcolemmal ATP-sensitive K+ channels in a gender-dependent manner.

Authors:  Harri J Ranki; Russell M Crawford; Grant R Budas; Aleksandar Jovanović
Journal:  Mech Ageing Dev       Date:  2002-03-31       Impact factor: 5.432

View more
  8 in total

Review 1.  Interaction of nucleoside diphosphate kinase B with heterotrimeric G protein betagamma dimers: consequences on G protein activation and stability.

Authors:  Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-03       Impact factor: 3.000

2.  Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma.

Authors:  David M Kaetzel; Mary K Leonard; Gemma S Cook; Marian Novak; Stuart G Jarrett; Xiuwei Yang; Alexey M Belkin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-15       Impact factor: 3.000

3.  The ubiquitin E3 ligase SCF-FBXO24 recognizes deacetylated nucleoside diphosphate kinase A to enhance its degradation.

Authors:  Wei Chen; Sheng Xiong; Jin Li; Xiuying Li; Yuan Liu; Chunbin Zou; Rama K Mallampalli
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

4.  Overexpression of AMPKalpha1 Ameliorates Fatty Liver in Hyperlipidemic Diabetic Rats.

Authors:  Eunhui Seo; Eun-Jin Park; Yeonsoo Joe; Soojeong Kang; Mi-Sun Kim; Sook-Hee Hong; Mi-Kyoung Park; Duk Kyu Kim; Hyongjong Koh; Hye-Jeong Lee
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

Review 5.  Regulators affecting the metastasis suppressor activity of Nm23-H1.

Authors:  Hag Dong Kim; Buhyun Youn; Tae-Sung Kim; Sang-Hwa Kim; Hyun-Seock Shin; Joon Kim
Journal:  Mol Cell Biochem       Date:  2009-04-18       Impact factor: 3.396

6.  AMPK directly inhibits NDPK through a phosphoserine switch to maintain cellular homeostasis.

Authors:  Rob U Onyenwoke; Lawrence J Forsberg; Lucy Liu; Tyisha Williams; Oscar Alzate; Jay E Brenman
Journal:  Mol Biol Cell       Date:  2011-11-23       Impact factor: 4.138

Review 7.  The cystic fibrosis transmembrane recruiter the alter ego of CFTR as a multi-kinase anchor.

Authors:  Anil Mehta
Journal:  Pflugers Arch       Date:  2007-09-06       Impact factor: 3.657

8.  Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma.

Authors:  M Kathryn Leonard; Joseph R McCorkle; Devin E Snyder; Marian Novak; Qingbei Zhang; Amol C Shetty; Anup A Mahurkar; David M Kaetzel
Journal:  Lab Invest       Date:  2017-10-23       Impact factor: 5.662

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.